American Society of Echocardiography
Figure 1 shows the milestones of this development
Ongoing Mechanistic Trials of GLP-1RAs in Patients Without Diabetes Mellitus GLP-1 RAs are also being studied in patients other than those with T2D, including individuals with obesity and after bariatric surgery, as well as people with chronic obstructive pulmonary disease, PCOS, NAFLD/nonalcoholic steatohepatitis, osteoarthritis, HIV, Alzheimer disease, Parkinson disease, schizophrenia, tobacco dependence, alcohol dependence, and craniopharyngioma
Many patients report improved tolerability when starting at this conservative dose rather than beginning at higher levels
(A, B) Top 10 upregulated gene pathways according to KEGG database (A) and WikiPathways (BD) Top 10 downregulated gene pathways according to KEGG database (C) and WikiPathways (D)